Biolife Solutions Inc’s recently made public that its Chief Marketing Officer Berard Todd unloaded Company’s shares for reported $2397.0 on Nov 12 ’24. In the deal valued at $26.34 per share,91 shares were sold. As a result of this transaction, Berard Todd now holds 107,756 shares worth roughly $2.27 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Foster Karen A. sold 66 shares, generating $1,738 in total proceeds. Upon selling the shares at $26.34, the Chief Quality and Operations now owns 157,225 shares.
Before that, Mathew Aby J. sold 123 shares. Biolife Solutions Inc shares valued at $3,240 were divested by the EVP & Chief Scientific Officer at a price of $26.34 per share. As a result of the transaction, Mathew Aby J. now holds 317,046 shares, worth roughly $6.66 million.
H.C. Wainwright initiated its Biolife Solutions Inc [BLFS] rating to a Buy in a research note published on September 30, 2024; the price target was $29. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early April with a ‘”a Buy”‘ rating. Craig Hallum began covering BLFS with “Buy” recommendation on July 11, 2023. Oppenheimer revised its rating on April 25, 2022. It rated BLFS as “an Outperform” which previously was an “a Perform”.
Price Performance Review of BLFS
On Friday, Biolife Solutions Inc [NASDAQ:BLFS] saw its stock fall -2.91% to $21.02. Over the last five days, the stock has lost -19.56%. Biolife Solutions Inc shares have risen nearly 29.35% since the year began. Nevertheless, the stocks have risen 70.34% over the past one year. While a 52-week high of $28.88 was reached on 11/13/24, a 52-week low of $11.40 was recorded on 03/01/24. SMA at 50 days reached $24.00, while 200 days put it at $21.18.
Levels Of Support And Resistance For BLFS Stock
The 24-hour chart illustrates a support level at 20.52, which if violated will result in even more drops to 20.01. On the upside, there is a resistance level at 21.77. A further resistance level may holdings at 22.51. The Relative Strength Index (RSI) on the 14-day chart is 34.62, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.41, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 96.80%. Stochastics %K at 15.05% indicates the stock is a buying.
How much short interest is there in Biolife Solutions Inc?
A steep rise in short interest was recorded in Biolife Solutions Inc stocks on 2024-10-31, dropping by 51414.0 shares to a total of 3.5 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 3.55 million shares. There was a decline of -1.47%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on October 19, 2021 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $61 price target.
